Literature DB >> 28819916

Early Surgical Intervention for Acute Ulcerative Colitis Is Associated with Improved Postoperative Outcomes.

Ira L Leeds1, Brindusa Truta2, Alyssa M Parian2, Sophia Y Chen1, Jonathan E Efron1, Susan L Gearhart1, Bashar Safar1, Sandy H Fang3.   

Abstract

BACKGROUND: Timing of surgical intervention for acute ulcerative colitis has not been fully examined during the modern immunotherapy era. Although early surgical intervention is recommended, historical consensus for "early" ranges widely. The purpose of this study was to evaluate outcomes according to timing of urgent surgery for acute ulcerative colitis.
METHODS: All non-elective total colectomies in ulcerative colitis patients were identified in the National Inpatient Sample from 2002 to 2014. Procedures, comorbidities, diagnoses, and in-hospital outcomes were collected using International Classification of Disease, 9th Revision codes. An operation was defined as early if within 24 hours of admission. Results were compared between the early versus delayed surgery groups.
RESULTS: We found 69,936 patients that were admitted with ulcerative colitis, and 2650 patients that underwent non-elective total colectomy (3.8%). Early intervention was performed in 20.4% of patients who went to surgery. More early operations were performed laparoscopically (28.1% versus 23.3%, p = 0.021) and on more comorbid patients (Charlson Index, p = 0.008). Median total hospitalization costs were $20,948 with an early operation versus $33,666 with a delayed operation (p < 0.001). Delayed operation was an independent risk for a complication (OR = 1.46, p = 0.001). Increased hospitalization costs in the delayed surgery group were statistically significantly higher with a reported complication (OR = 3.00, p < 0.001) and lengths of stay (OR = 1.26, p < 0.001).
CONCLUSION: Delayed operations for acute ulcerative colitis are associated with increased postoperative complications, increased lengths of stay, and increased hospital costs. Further prospective studies could demonstrate that this association leads to improved outcomes with immediate surgical intervention for medically refractory ulcerative colitis.

Entities:  

Keywords:  Colectomy; Emergency surgery; Refractory; Ulcerative colitis

Mesh:

Year:  2017        PMID: 28819916      PMCID: PMC6201293          DOI: 10.1007/s11605-017-3538-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Practice parameters for the surgical treatment of ulcerative colitis.

Authors:  Howard Ross; Scott R Steele; Mika Varma; Sharon Dykes; Robert Cima; W Donald Buie; Janice Rafferty
Journal:  Dis Colon Rectum       Date:  2014-01       Impact factor: 4.585

2.  An experience of ulcerative colitis. I. Toxic dilation in 55 cases.

Authors:  K N Jalan; W Sircus; W I Card; C W Falconer; C B Bruce; G P Crean; J P McManus; W P Small; A N Smith
Journal:  Gastroenterology       Date:  1969-07       Impact factor: 22.682

3.  Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation.

Authors:  J C Goligher; D C Hoffman; F T de Dombal
Journal:  Br Med J       Date:  1970-12-19

4.  Management of acute colitis and toxic megacolon.

Authors:  Scott A Strong
Journal:  Clin Colon Rectal Surg       Date:  2010-12

5.  Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial.

Authors:  S Meyers; P K Lerer; E J Feuer; J W Johnson; H D Janowitz
Journal:  J Clin Gastroenterol       Date:  1987-02       Impact factor: 3.062

6.  GI distension in severe ulcerative colitis.

Authors:  Giovanni Latella; Piero Vernia; Angelo Viscido; Giuseppe Frieri; Giuseppina Cadau; Andrea Cocco; Andrea Cossu; Ernesto Tomei; Renzo Caprilli
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

7.  Influence of weekend versus weekday hospital admission on mortality following subarachnoid hemorrhage. Clinical article.

Authors:  R Webster Crowley; Hian K Yeoh; George J Stukenborg; Adina A Ionescu; Neal F Kassell; Aaron S Dumont
Journal:  J Neurosurg       Date:  2009-07       Impact factor: 5.115

8.  Outcomes of weekend admissions for upper gastrointestinal hemorrhage: a nationwide analysis.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-19       Impact factor: 11.382

9.  Colectomy rate in acute severe ulcerative colitis in the infliximab era.

Authors:  A Aratari; C Papi; V Clemente; A Moretti; R Luchetti; M Koch; L Capurso; R Caprilli
Journal:  Dig Liver Dis       Date:  2008-05-09       Impact factor: 4.088

10.  Intensive intravenous treatment of ulcerative colitis.

Authors:  G Järnerot; P Rolny; H Sandberg-Gertzén
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

View more
  8 in total

1.  Outcomes for Ulcerative Colitis With Delayed Emergency Colectomy Are Worse When Controlling for Preoperative Risk Factors.

Authors:  Ira L Leeds; Margaret H Sundel; Alodia Gabre-Kidan; Bashar Safar; Brindusa Truta; Jonathan E Efron; Sandy H Fang
Journal:  Dis Colon Rectum       Date:  2019-05       Impact factor: 4.585

Review 2.  The Management of the Hospitalized Ulcerative Colitis Patient: the Medical-Surgical Conundrum.

Authors:  Michele Carvello; Joseph Watfah; Marcin Włodarczyk; Antonino Spinelli
Journal:  Curr Gastroenterol Rep       Date:  2020-02-10

3.  An automated machine learning-based model predicts postoperative mortality using readily-extractable preoperative electronic health record data.

Authors:  Brian L Hill; Robert Brown; Eilon Gabel; Nadav Rakocz; Christine Lee; Maxime Cannesson; Pierre Baldi; Loes Olde Loohuis; Ruth Johnson; Brandon Jew; Uri Maoz; Aman Mahajan; Sriram Sankararaman; Ira Hofer; Eran Halperin
Journal:  Br J Anaesth       Date:  2019-10-15       Impact factor: 9.166

4.  Delay in emergency hernia surgery is associated with worse outcomes.

Authors:  Ira L Leeds; Christian Jones; Sandra R DiBrito; Joseph V Sakran; Elliott R Haut; Alistair J Kent
Journal:  Surg Endosc       Date:  2019-11-18       Impact factor: 4.584

Review 5.  WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting.

Authors:  Belinda De Simone; Justin Davies; Elie Chouillard; Salomone Di Saverio; Frank Hoentjen; Antonio Tarasconi; Massimo Sartelli; Walter L Biffl; Luca Ansaloni; Federico Coccolini; Massimo Chiarugi; Nicola De'Angelis; Ernest E Moore; Yoram Kluger; Fikri Abu-Zidan; Boris Sakakushev; Raul Coimbra; Valerio Celentano; Imtiaz Wani; Tadeja Pintar; Gabriele Sganga; Isidoro Di Carlo; Dario Tartaglia; Manos Pikoulis; Maurizio Cardi; Marc A De Moya; Ari Leppaniemi; Andrew Kirkpatrick; Vanni Agnoletti; Gilberto Poggioli; Paolo Carcoforo; Gian Luca Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-05-11       Impact factor: 5.469

6.  Glucocorticoids Promote the Onset of Acute Experimental Colitis and Cancer by Upregulating mTOR Signaling in Intestinal Epithelial Cells.

Authors:  Zhengguo Zhang; Lin Dong; Anna Jia; Xi Chen; Qiuli Yang; Yufei Wang; Yuexin Wang; Ruichen Liu; Yejin Cao; Ying He; Yujing Bi; Guangwei Liu
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

7.  Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis.

Authors:  Matthew J Brookes; John Waller; Joseph C Cappelleri; Irene Modesto; Marco D DiBonaventura; Natalie Bohm; Ruth Mokgokong; Olivia Massey; Robert Wood; Danielle Bargo
Journal:  BMJ Open Gastroenterol       Date:  2020-09

8.  Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome.

Authors:  Natsuki Ishida; Takahiro Miyazu; Satoshi Tamura; Shinya Tani; Mihoko Yamade; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.